HeiQ Viroblock NPJ03 is among the first textile technologies in the world to be proven effective against SARS-CoV-2 in the laboratory. SARS-CoV-2 is an enveloped virus from the coronavirus family that causes COVID-19. Tests have been conducted by HeiQ with the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia (Doherty Institute). HeiQ Viroblock is designed to inhibit the growth and persistence of bacteria and enveloped viruses on textile surfaces. It’s a unique combination of registered silver technology for antiviral and antibacterial effect and vesicle technology as a booster.